Functional analysis of the interleukin-5 receptor antagonist peptide, AF18748

Cytokine

Volumn 26, Issue 6, 2004, Pages 247-254

  Rosas, Marcela ^a   Uings, Iain J ^b   Van Aalst, Cornelli ^a   Lammers, Jan Willem J ^a   Koenderman, Leo ^a   Coffer, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Chain; Cytokines; Eosinophils; IL 5; Signaling pathways

Indexed keywords

AF 18748; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR ANTAGONIST; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DIMERIZATION; EOSINOPHIL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; HUMANS; INTERLEUKIN-5; MICE; PEPTIDES; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; SIGNAL TRANSDUCTION;

EID: 2942588801     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.10.012     Document Type: Article

References (27)

1. Gleich G.J. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol. 85:1990;422-436
2. Gleich G.J. Mechanisms of eosinophils-associated inflammation. J Allergy Clin Immunol. 105:(4):2000;651-663
3. Roboz G.J., Rafii S. Interleukin-5 and the regulation of eosinophil production. Curr Opin Hematol. 6:(3):1999;164-168
4. Weltman J.K., Karim A.S. IL-5: biology and potential therapeutic applications. Expert Opin Investig Drugs. 9:(3):2000;491-496
5. Fujisawa T., Abu-Ghazaleh R., Kita H., Sanderson C.J., Gleich G.J. Regulatory effect of cytokines on eosinophil degranulation. J Immunol. 144:1990;642-646
6. Devos R., Plaetinck G., Cornelis S., Guisez Y., Van der Heyden J., Tavernier J. Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic allergic disease. J Leukoc Biol. 57:1995;813-819
7. Sanderson C.J., Urwin D. Interleukin-5: a drug target for allergic diseases. Curr Opin Investig Drugs. 1:2000;435-441
8. Uings I., Mckinnon M. Development of IL-5 receptor antagonists. Curr Pharm Des. 8:2002;1837-1844
9. Tavernier J., Devos R., Cornelis S., Tuypens T., Van der Heyden J., Fiers W., et al. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell. 66:(6):1995;1175-1184
10. Cameron L., Christodoulopoulos P., Lavigne F., Nakamura Y., Eidelman D., McEuen A., et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble receptor. J Immunol. 164:2000;1539-1545
11. Tavernier J., Tuypens T., Verhee A., Plaentinck G., Devos R., Van der Heyden J., et al. Identification of receptor-binding domains on human interleukin-5 and design of an interleukin-5 derived receptor antagonist. Proc Natl Acad Sci U S A. 92:1995;5194-5198
12. Mckinnon M., Page K., Uings I.J., Banks M., Fattah D., Proudfoot A.E.I., et al. An interleukin 5 mutant distinguishes between two functional responses in human eosinophils. J Exp Med. 186:1997;121-129
13. Zhang J., Kuvelkar R., Murgolo N., Taremi S., Chou C.C., Wang P., et al. Mapping and characterization of the epitope(s) of Sch 55700, a humanized mAb, that inhibits human IL-5. Int Immunol. 11:1999;1935-1943
14. England B., Balasubramanian P., Uings I., Bethell S., Chen M.J., Schatz P., et al. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin receptor α-chains. Proc Natl Acad Sci U S A. 12:2000;6862-6867
15. Geijsen N., Uings I.J., Pals C., Armstrong J., McKinnon M., Raaijmakers J.A., et al. Cytokine-specific transcriptional regulation through an IL-5R alpha interacting protein. Science. 293:2001;1136-1138
16. Bagley C.J., Woodcock J.M., Stomski F.C., Lopez A.F. The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors. Blood. 89:(5):1997;1471-1482
17. Adachi T., Alam R. The mechanism of IL-5 signal transduction. Am J Physiol. 275:(3):1998;C623-C633
18. 21 of GM-CSF. EMBO J. 13:(21):1994;5176-5185
19. Rossjohn J., Mckintry W.J., Woodcock J.M., McClure B.J., Hercus T.R., Parker M.W., et al. Structure of the activation domain of GM-CSF/IL-3/IL-5 receptor common β-chain bound to an antagonist. Blood. 95:2000;2491-2497
20. Carr P.D., Gustin S.E., Church A.P., Murphy J.M., Ford S.C., Mann D.A., et al. Structure of the complete extracellular domain of the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors reveals a novel dimer configuration. Cell. 104:2001;291-300
21. Cornelis S., Geert P., Devos R., Van der Heyden J., Tavernier J., Sanderson C., et al. Detailed analysis of the IL-5-IL5Rα interaction: characterization of crucial residues on the ligand and the receptor. EMBO J. 14:(14):1995;3395-3402
22. Uings I.J., Balasubramanian P., McLoughlin P.G., Yin Q., Dash L., Beresford A., et al. Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificity. Cytokine. 15:(1):2001;10-19
23. Koenderman L., Kok P.T., Hamelink M.L., Verhoeven A.J., Bruijnzeel P. An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. J Leuk Biol. 44:(2):1988;79-86
24. Caldenhoven E., van Dijk T., Raaijmakers J.A., Lammers J.W., Koenderman L., De Groot R.P. Activation of the STAT3/acute phase response factor transcription factor by interleukin-5. J Biol Chem. 270:(43):Oct 27 1995;25778-25784
25. Fattah D., Page K.R., Bezbaruah S., Priest R.C., Horgan C.M., Solari R. A rapid activation assay for human eosinophils based on adhesion to immobilized ICAM-1, VCAM-1 and IgG. Cytokine. 8:(3):1996;248-259
26. Schweizer R.C., van Kessel-Welmers B.A., Warringa R.A., Maikoe T., Raaijmakers J.A., Lammers J.W., et al. Mechanisms involved in eosinophil migration. Platelet-activating factor-induced chemotaxis and interleukin-5-induced chemokinesis are mediated by different signals. J Leukoc Biol. 59:(3):1996;347-356
27. Weening R.S., Roos D., Loos J.A. Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study. J Lab Clin Med. 83:1974;570-577